Event Brief
Health Canada approves second Alzheimer’s drug
Filed: May 04, 2026 at 1:03 PM ET
Summary: Health Canada approved a second drug to slow Alzheimer’s, following approval of lecanemab in October 2025.
WHO: Health Canada
WHAT: Approval of a second Alzheimer’s disease-slowing drug in Canada
WHEN: May 04, 2026 at 12:21 PM ET
WHERE: Canada
WHY: No specific cause was reported.
ℹ️ This event is analyzed using pattern arcs, velocity indicators, and source analysis in our MI Console.
Know more. Read less.
The BriefBrief follows the story, so you don't have to read every article. See what happened, how it changed, and where it came from, all in one place.
Same format. Every time.
See how stories unfold →